Curanex Pharmaceuticals Inc Common Stock (NASDAQ: CURX) — Healthcare · Share Price, Chart & Market Data
About: Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients suffering from inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout. The company was formerly known as Fordman Pharma Inc. and changed its name to Curanex Pharmaceuticals Inc in November 2023. Curanex Pharmaceuticals Inc was founded in 1996 and is headquartered in Jericho, New York.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.44 (-1.38%)
CURXCuranex Pharmaceuticals Inc Common Stock
Loading watchlist status…
Trade CURX now
Curanex Pharmaceuticals Inc Common Stock share price
CURX price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 8:56 am GMT+0
CURX price performance
-8.193%
5D
-14.732%
1M
18.75%
YTD
-89.129%
1Y
CURX price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 8:56 am GMT+0
CURX details
CURX Market Signals